Skip to content
Live newsroom 39 readers online
Saturday, September 5, 2026 Live Sync: Just now
Trending:
Nifty 50 BSE Sensex Indian Auto AI & Tech F1 Racing Share suggestions Crypto & Commodities
BreakingHeineken pours Asia-Pacific beer efforts into Vietnam expansion
Important

The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease. Source: Read the original article on www.nytimes.com

By deepak · September 4, 2026 · 1 min read

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

Source: Read the original article on www.nytimes.com

Related Coverage

Trump Issues Ultimatum to Fed: Cut Rates or Face Trade War With...

September 4, 2026

E20 won't be replaced by E10, BPCL says amid debate over older...

August 28, 2026

What to Know About Venezuelan Energy Following Trump’s Oil Deal

September 1, 2026

Important Legal & Financial Disclaimer

FutureKnowledge is an automated financial intelligence aggregator. The information provided on this website does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the website's content as such. We are not registered with the SEC, SEBI, or any regulatory agency. Automated AI-generated content may contain errors. Always conduct your own due diligence and consult your financial advisor before making any investment decisions.

© 2026 FutureKnowledge Intelligence. All rights reserved.